Bronchial asthma: A disease of both large and small airways;Een aandoening van grote én kleine luchtwegen

Pharmaceutisch Weekblad

Volumn 137, Issue 1, 2002, Pages 14-15

  Dekhuijzen, P N R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID;

AIRWAY; AIRWAY RESISTANCE; ARTICLE; ASTHMA; DRUG EFFICACY; HUMAN; MORPHOLOGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; STEROID THERAPY;

EID: 18344399576     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Peripheral lung resistance in normal and asthmatic subjects
2. Differences in airway closure between normal and asthmatic subjects measured with single-photon emission computed tomography and technegas
3. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes
4. Airway-parenchyma uncoupling in nocturnal asthma
5. Inflammation of small airways in asthma
6. Inflammatory cell distribution within and along asthmatic airways
7. Alveolar tissue inflammation in asthma
8. Cyclooxygenase metabolites in human lung anaphylaxis: Airway vs. parenchyma
9. Immediate allergic response in small airways
10. Inhalatiemedicatie bij volwassenen met obstructieve longaandoeningen: Poeder of aërosol?
11. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma
12. Effect of formulation parameters on hydrofluoroalkanebeclomethasone dipropionate drug deposition in humans
13. Glucocorticoid receptor localization in normal and asthmatic lung
14. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: Assessment with functional helical thin-section computed tomography
15. Tumour necrosis factoralpha production in human alveolar macrophages: Modulation by inhaled corticosteroid
16. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant
17. Adrenal effects and pharmacokinetics of CFC-free beclomethasone diproprionate: A 14 day dose-response study
18. Inhaled corticosteroids and the hypothalamic-pituitary-adrenal (HPA) axis: Do we understand their interaction?